Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014) [Phase 1]
Phase 1 trial evaluating safety, tolerability, and effects of MK-0974 (Telcagepant) on exercise tolerance in stable angina patients complete…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Efficacy and Safety of Lacidipine in Chronic Stable Angina [Phase 2]
Phase 2 trial evaluating lacidipine for chronic stable angina has completed, reporting efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study [Phase 4]
A Phase 4 clinical trial update reports the completion of a study evaluating intravascular near-infrared spectroscopy (NIRS) bifurcation to …
-
FDA approval · 2014-08-27FDA Approved: METOPROLOL TARTRATE — Original Application (Almaject, Inc.)
FDA approved Almaject, Inc.'s metoprolol tartrate as an original Abbreviated New Drug Application (ANDA), establishing a generic version of …
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Second Generation" Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy [Phase 3]
This Phase 3 trial evaluated six versus twelve months of dual antiplatelet therapy after implantation of second-generation drug-eluting sten…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-28FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2014-07-19FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate filed by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS withdrawal · 2014-07-02Clinical Trial Update: A Multi-centric Study to Assess the Efficacy of Sigmart in Subjects With Recurrent Angina After Coronary Revascularization [Phase 4]
A Phase 4 multicenter trial evaluating Sigmart for recurrent angina after coronary revascularization has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-09Clinical Trial Update: Hybrid Intraprocedural Imaging Based on 2 Different Imaging Methods [NA]
A clinical trial evaluating hybrid intraprocedural imaging methods for angina pectoris and left ventricular wall motion abnormalities has be…
-
CLINICAL_TRIALS research · 2014-06-06Clinical Trial Update: Vein vs Arterial Grafts for Coronary Artery Bypass Grafting Surgery [NA]
Update on a clinical trial comparing vein grafts versus arterial grafts for coronary artery bypass grafting; no status or results are provid…
-
FDA label_change · 2014-05-06FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Procardia XL (nifedipine) from Pfizer Laboratories to update the product labeling.
-
FDA label_change · 2014-05-06FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) filed by Melinta Therapeutics, resulting in labeling changes fo…
-
FDA approval · 2014-04-30FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Cardene IV (nicardipine hydrochloride) submitted by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS research · 2014-04-29Clinical Trial Update: Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes [Phase 4]
A Phase 4 clinical trial update on coronary angioplasty outcomes in octogenarians with emergent coronary syndromes, including NSTEMI and uns…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
This ClinicalTrials.gov update notes the completed status and posted results of CardioDx's gene expression test Corus CAD (ASGES) used to ai…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Women's Ischemia Syndrome Evaluation (WISE) [Phase 3]
Clinical trial update indicating the Phase 3 Women's Ischemia Syndrome Evaluation (WISE) study has completed.
-
FDA approval · 2014-04-03FDA Approved: NIFEDIPINE — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' original ANDA for a generic nifedipine product.
-
FDA approval · 2014-03-07FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Nitrostat (nitroglycerin) from Viatris Specialty LLC.
-
FDA approval · 2014-01-27FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for METOPROLOL SUCCINATE submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2014-01-23FDA Approved: FELODIPINE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for felodipine from Endo USA, Inc. under the approved ANDA.
-
FDA approval · 2013-12-31FDA Approved: NITROGLYCERIN IN DEXTROSE — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter Healthcare Company's supplemental NDA for Nitroglycerin in Dextrose, authorizing the nitroglycerin-in-dextrose formulati…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina [Phase 2]
A Phase 2 trial comparing febuxostat to placebo assessed exercise tolerance in participants with chronic stable angina; the study was termin…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Platelet-Inhibitor Drug Trial in Coronary Angioplasty [Phase 3]
A Phase 3 clinical trial evaluating a platelet-inhibitor drug in patients undergoing coronary angioplasty has completed.
-
FDA approval · 2013-11-19FDA Approved: INNOPRAN XL — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for INNOPRAN XL (propranolol hydrochloride). The approval confirms changes to the…
-
FDA approval · 2013-11-08FDA Approved: FELODIPINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic felodipine under an Abbreviated New Drug Application by Heritage Pharmaceuticals (Avet) to treat hypertension and ang…